Clinical Trials Browser

Skin Diseases × methyl 5-aminolevulinate × Clear all

NCT01491711 2014-01-31

Superficial Basal Cell Carcinoma Treatment With Topical Photodynamic Therapy With Fractionated 5-aminolevulinic Acid 20% Versus Two Stage Methylaminolevulinate

Phase 4 Unknown

Carcinoma, Basal Cell, Connective Tissue Diseases, Skin Diseases